Inhibitory effects of galanin on growth hormone (GH) release in cultured GH-secreting adenoma cells: Comparative study with octreotide, GH-releasing hormone, and thyrotropin-releasing hormone

Metabolism: Clinical and Experimental

Volumn 46, Issue 4, 1997, Pages 425-430

  Giustina, Andrea ^a   Ragni, Giorgio ^b   Bollati, Angelo ^b   Cozzi, Renato ^b   Licini, Massimo ^b   Poiesi, Claudio ^b   Turazzi, Sergio ^b   Bonfanti, Carlo ^b  

^a SPEDALI CIVILI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GONADORELIN DERIVATIVE; GROWTH HORMONE; OCTREOTIDE; PROTIRELIN; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0030952303     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90060-3     Document Type: Article

References (25)

1. Palkovits M, Rokaeus A, Antony FA, et al: Galanin: A newly isolated biologically active neuropeptide. Neuroendocrinology 46:417-423, 1987
2. Giustina A, Licini M, Schettino M, et al: Physiological role of galanin in the regulation of anterior pituitary function in humans. Am J Physiol 266:E57-E61, 1994
3. Giustina A, Girelli A, Bodini C, et al: Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. Horm Metab Res 24:90-91, 1992
4. Ottelcz A, Samson W, McCann SM: Galanin: Evidence for a hypothalamic site of action to release growth hormone. Peptides 7:51-53, 1985
5. Melmed S, Braunstein GD, Horvath E, et al: Pathophysiology of acromegaly. Endocr Rev 4:271-290, 1983
6. Lamberts SWJ, Krenning EP, Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482, 1991
7. Renner U, Brockmeier C, Strasburger CJ, et al: Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: Interaction with GH releasing hormone, thyrotropin releasing hormone, and octreotide. J Clin Endocrinol Metab 78:1090-1096, 1994
8. Giustina A, Bresciani E, Bussi AR, et al: Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. J Clin Endocrinol Metab 80:1333-1340, 1995
9. 1) in culture. Life Sci 55:1845-1851, 1994
10. Gabriel ST, Milbury CM, Nathanson JA, et al: Galanin stimulates rat pituitary growth hormone secretion in vitro. Life Sci 41:1981-1986, 1988
11. Torsello A, Sellan R, Cella SG, et al: Age dependent modulation by galanin of growth hormone release from rat pituitary cells in culture. Life Sci 47:1861-1866, 1990
12. Adams EF, Brajkovich IE, Mashiter K: Growth hormone and prolactin secretion by dispersed cell cultures of human pituitary adenomas: Long-term effects of hydrocortisone, estradiol, insulin, 3,5,3′-triiodothyronine and thyroxine. J Clin Endocrinol Metab 53:381-385, 1981
13. Giustina A, Licini M, Bussi AR, et al: Effects of sex and age on the growth hormone response to galanin in healthy human subjects. J Clin Endocrinol Metab 76:1369-1372, 1993
14. Murakami Y, Kato Y, Shimatsu A, et al: Possible mechanism involved in growth hormone secretion induced by galanin in the rat. Endocrinology 124:1224-1229, 1989
15. Giustina A, Bussi AR, Legati F, et al: Galanin does not affect the growth hormone (GH)-releasing hormone-stimulated GH secretion in patients with hyperthyroidism. Acta Endocrinol (Copenh) 127:504-508, 1992
16. Melmed S: Comprehensive management of acromegaly. Metabolism 44:27-30, 1995
17. Greenman Y, Melmed S: Expression of three somatostatin receptor subtypes in pituitary adenomas: Evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 79:724-729, 1994
18. Kubota A, Yamada Y, Waser B, et al: Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93:1321-1325, 1994
19. Habert-Ortioli E, Amiranoff B,Loquet I, et al: Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 91:9780-9783, 1994
20. Lagny-Pourmir I, Amiranoff B, Lorinet AM, et al: Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: Evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein. Endocrinology 124:2635-2641, 1988
21. Amiranoff B, Lorinet AM, Lagny-Pourmir I, et al: Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxinsensitive inhibition of adenylate cyclase. Eur J Biochem 177:147-152, 1988
22. Spada A, Bassetti M, Arosio M, et al: The hypersecreting somatotroph: Functional and morphological aspects, in Muller EE, Cocchi D, Locatelli V (eds): Advances in Growth Hormone and Growth Factor Research. Roma-Milano, Italy, Pytagora, 1989, pp 411-421
23. Geras EJ, Gershengorn MC: Evidence that TRH stimulates secretion of TSH by two calcium-mediated mechanisms. Am J Physiol 242:E109-E113, 1982
24. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 340:566-568, 1987
25. Spada A, Arosio M, Bochicchio D, et al: Clinical, biochemical and morphological correlates in patients bearing growth hormonesecreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71:1421-1426, 1990